e-Drug3D

416

CARMUSTINE


INN
CARMUSTINE

cas 154-93-8
CLASS

ANTINEOPLASTIC
ALKYLATING
NITROSOUREAS
CARBAMOYLATION OF AMINO ACIDS IN PROTEINS

ROUTE (list)

INJECTION INTRACRANIAL INTRAVENOUS

ATC code

L01AD01

PK parameters

VD 78 LITER (65 KILOGRAM)
Cl 304 LITER / HOUR (65 KILOGRAM)
PPB 77 PERCENT
t1/2 0.37 HOUR

Target

TARGET DNA
RNA

DrugCentral

Glutathione reductase, mitochondrial UNIPROT P00390 GSR

Download SDF file 1,3-bis(2-chloroethyl)-1-nitrosourea

Formula:
C5H9Cl2N3O2

Calculated chemical properties:

MW 214.05
NB_atoms 12
XLogP 1.16
PSA 57.988
NB_HD 1
NB_HA 5
fsp3 0.80
Lipinski(0=no;1=yes) 1

FDA
NDA 017422 (pdf not found) INN (CARMUSTINE) BICNU (AVET LIFESCIENCES) APPROVAL= AP YEAR= 1977
NDA 020637 (pdf not found) INN (CARMUSTINE) GLIADEL (AZURITY) APPROVAL= AP YEAR= 1996
NDA 210179 (pdf not found) INN (CARMUSTINE) CARMUSTINE (NAVINTA LLC) APPROVAL= AP YEAR= 2018
NDA 211229 (pdf not found) INN (CARMUSTINE) CARMUSTINE (AMNEAL) APPROVAL= AP YEAR= 2018
NDA 209278 (pdf not found) INN (CARMUSTINE) CARMUSTINE (PENN LIFE) APPROVAL= AP YEAR= 2019
NDA 213207 (pdf not found) INN (CARMUSTINE) CARMUSTINE (DR REDDYS) APPROVAL= AP YEAR= 2020
NDA 211202 (pdf not found) INN (CARMUSTINE) CARMUSTINE (HENGRUI PHARMA) APPROVAL= AP YEAR= 2021
NDA 213460 (pdf not found) INN (CARMUSTINE) CARMUSTINE (MEITHEAL) APPROVAL= AP YEAR= 2021
NDA 211011 (pdf not found) INN (CARMUSTINE) CARMUSTINE (INGENUS PHARMS LLC) APPROVAL= AP YEAR= 2022 DISCONTINUED
NDA 215000 (pdf not found) INN (CARMUSTINE) CARMUSTINE (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2022 DISCONTINUED
NDA 214117 (pdf not found) INN (CARMUSTINE) CARMUSTINE (ACCORD HLTHCARE) APPROVAL= AP YEAR= 2022 DISCONTINUED
NDA 214814 (pdf not found) INN (CARMUSTINE) CARMUSTINE (MSN) APPROVAL= AP YEAR= 2023
NDA 215368 (pdf not found) INN (CARMUSTINE) CARMUSTINE (PHARMOBEDIENT) APPROVAL= AP YEAR= 2023 DISCONTINUED
NDA 215730 (pdf not found) INN (CARMUSTINE) CARMUSTINE (ALEMBIC) APPROVAL= AP YEAR= 2023

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL